Rose Crane

Rose Crane has extensive experience in the pharmaceutical industry, currently serving as a Board Member at Tarsus Pharmaceuticals, Inc. and Certara, as well as a Member of the Board of Directors at Teva Pharmaceuticals and Catalent Pharma Solutions. Previous roles include Vice Chairman at Zealand Pharma, CEO at MELA Sciences, Inc. and Epocrates, Inc., and Partner at appletree partners. Additionally, Rose held the position of Company Group Chairman at Johnson & Johnson and served as President of US Primary Care at Bristol-Myers Squibb. Rose holds a Master of Business Administration from Kent State University and a Bachelor of Arts in Communications from the State University of New York at Oswego.